AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | 219.54 | 134.10 | 83.04 | 127.09 | 113.97 |
| Net cashflow-operating activity | 27.87 | 58.29 | 100.80 | 104.78 | 87.42 |
| Net cash used in investing activity | 21.74 | 18.11 | 4.74 | 173.03 | -170.80 |
| Netcash used in fin. activity | -44.38 | -24.48 | -9.46 | -8.97 | -6.36 |
| Net inc/dec in cash and equivlnt | 5.23 | 51.92 | 96.08 | 268.84 | -89.74 |
| Cash and equivalnt begin of year | 500.34 | 448.42 | 352.34 | 83.50 | 173.24 |
| Cash and equivalnt end of year | 505.57 | 500.34 | 448.42 | 352.34 | 83.50 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis